Question 1

Does Ensign Peak Advisors own DNLI stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ensign Peak Advisors holds 582,669 shares of DNLI (Denali Therapeutics), worth $15M.

Question 2

How many shares of DNLI does Ensign Peak Advisors own?

Accepted Answer

As of its Q2 2026 13F, Ensign Peak Advisors holds 582,669 shares of DNLI (Denali Therapeutics).

Question 3

What is Ensign Peak Advisors' DNLI position worth?

Accepted Answer

As of its Q2 2026 13F, Ensign Peak Advisors' DNLI position is worth $15M.

Question 4

Is Ensign Peak Advisors buying or selling DNLI?

Accepted Answer

In Q2 2026, Ensign Peak Advisors increased its DNLI position by 66,948 shares (+13.0%).

Question 5

When did Ensign Peak Advisors first buy DNLI?

Accepted Answer

Ensign Peak Advisors already held DNLI in its Q4 2019 13F, the earliest on record, and has listed it in 27 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	582,669	+13.0%	$15M	0.0%	$25.72	32
2026-Q1	Unchanged	515,721	0.0%	$9.9M	0.0%	$20.02	0
2025-Q4	Decreased	515,721	-3.4%	$8.5M	0.0%	$16.41	0
2025-Q3	Increased	534,071	+12.8%	$7.8M	0.0%	$14.52	31
2025-Q2	Decreased	473,695	-19.4%	$6.6M	0.0%	$14.10	0
2025-Q1	Increased	587,785	+69.7%	$8M	0.0%	$14.78	41
2024-Q4	Unchanged	346,304	0.0%	$7.1M	0.0%	$20.24	0
2024-Q3	Unchanged	346,304	0.0%	$10.1M	0.0%	$29.43	0